Executive Director, Quantitative Pharmacology and Pharmacometrics
Merck
Dr. Matthew Rizk, PhD, is currently an Executive Director at Merck & Co., Inc. in the department of Quantitative Pharmacology & Pharmacometrics (QP2). Matt received his BS from Cornell University and his PhD from UCLA, both in Chemical Engineering, with research focused in the areas of metabolic engineering and synthetic biology. He then joined Merck Research Laboratories in 2009. He is the President-elect of ASCPT and serves on the editorial board of Clinical Pharmacology & Therapeutics (CPT).
Disclosure(s): Merck & Co., Inc.: Employment (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
Wednesday, March 27, 2024
5:00 PM – 6:30 PM MDT
Featured Speaker - Karthik Venkatakrishnan
Friday, March 29, 2024
8:15 AM – 9:00 AM MDT